JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
PETQ
4701
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $251K | ﹤0.01% |
21,939
+4,787
| +28% | +$53.2K |
2017 Q4
21 quarters
|
|
4702
Compañía de Cervecerías Unidas
CCU
$2.05B
| $250K | ﹤0.01% |
16,014
+142
| +0.9% | +$2.13K |
2014 Q4
33 quarters
|
|
4703
Destination XL Group
DXLG
$21.6M
| $250K | ﹤0.01% |
45,445
+6,514
| +17% | +$41.3K |
2022 Q2
3 quarters
|
|
4704
ProShares Ultra Semiconductors
USD
$3.2B
| $250K | ﹤0.01% |
34,580
+2,916
| +9% | +$16.9K |
2022 Q3
2 quarters
|
|
4705
John Hancock Multifactor Mid Cap ETF
JHMM
$6.01B
| $250K | ﹤0.01% |
5,201
-786
| -13% | -$38.2K |
2021 Q2
7 quarters
|
|
4706
Peoples Financial Services
PFIS
$693M
| $249K | ﹤0.01% |
5,746
+412
| +8% | +$20.2K |
2017 Q4
21 quarters
|
|
4707
Invesco International Corporate Bond ETF
PICB
$342M
| $249K | ﹤0.01% |
+11,450
| New | +$247K |
2023 Q1
0 quarters
|
|
4708
Preformed Line Products
PLPC
$2.06B
| $249K | ﹤0.01% |
1,947
+513
| +36% | +$51K |
2017 Q4
21 quarters
|
|
|
HLTH
4709
DELISTED
Cue Health Inc. Common Stock
HLTH
| $248K | ﹤0.01% |
135,902
-178,687
| -57% | -$388K |
2021 Q4
5 quarters
|
|
4710
MetroCity Bankshares
MCBS
$1B
| $247K | ﹤0.01% |
14,471
-360
| -2% | -$7.02K |
2019 Q4
13 quarters
|
|
4711
CALL
Wolfspeed
WOLF
$1.68B
| $247K | ﹤0.01% |
+3,800
| New | +$278K |
2023 Q1
0 quarters
|
|
4712
Invesco S&P MidCap Low Volatility ETF
XMLV
$694M
| $246K | ﹤0.01% |
4,699
| – | – |
2018 Q1
20 quarters
|
|
|
HLVX
4713
DELISTED
HilleVax
HLVX
| $246K | ﹤0.01% |
14,909
+3,561
| +31% | +$57K |
2022 Q2
3 quarters
|
|
4714
Chemung Financial Corp
CHMG
$394M
| $245K | ﹤0.01% |
5,900
+5,893
| +84,186% | +$283K |
2022 Q4
1 quarter
|
|
|
EMO
4715
ClearBridge Energy Midstream Opportunity Fund
EMO
$1.02B
| $245K | ﹤0.01% |
8,674
| – | – |
2021 Q4
5 quarters
|
|
|
DSKE
4716
DELISTED
Daseke, Inc. Common Stock
DSKE
| $245K | ﹤0.01% |
31,596
-5,856
| -16% | -$43K |
2017 Q3
22 quarters
|
|
|
ETNB
4717
PUT
DELISTED
89bio
ETNB
| $244K | ﹤0.01% |
+16,000
| New | +$209K |
2023 Q1
0 quarters
|
|
4718
SGHC Ltd
SGHC
$5.81B
| $244K | ﹤0.01% |
60,478
+59,997
| +12,473% | +$217K |
2022 Q4
1 quarter
|
|
|
PVLA
4719
Palvella Therapeutics
PVLA
$1.84B
| $244K | ﹤0.01% |
3,125
+2,543
| +437% | +$294K |
2017 Q3
22 quarters
|
|
|
EIM
4720
Eaton Vance Municipal Bond Fund
EIM
$454M
| $243K | ﹤0.01% |
+23,291
| New | +$239K |
2023 Q1
0 quarters
|
|
4721
908 Devices
MASS
$510M
| $243K | ﹤0.01% |
28,212
-34,212
| -55% | -$305K |
2021 Q1
8 quarters
|
|
4722
Kura Sushi USA
KRUS
$487M
| $242K | ﹤0.01% |
3,676
-4,179
| -53% | -$251K |
2019 Q3
14 quarters
|
|
4723
Oppenheimer Holdings
OPY
$1.29B
| $242K | ﹤0.01% |
6,198
+1,468
| +31% | +$64.5K |
2013 Q2
39 quarters
|
|
4724
PUT
Warner Bros
WBD
$77.6B
| $242K | ﹤0.01% |
16,000
-339,700
| -96% | -$4.83M |
2022 Q2
3 quarters
|
|
|
DNMR
4725
DELISTED
Danimer Scientific, Inc.
DNMR
| $242K | ﹤0.01% |
1,750
+453
| +35% | +$41.4K |
2021 Q1
8 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.